反応式
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]2[O:14][CH2:13][CH2:12][N:11](C(OC(C)(C)C)=O)[CH2:10][C@H:9]2[CH2:22][NH:23][C:24](=[O:28])[CH2:25][O:26][CH3:27])=[CH:4][C:3]=1[F:29].Cl.C(O)C>C(O)C>[ClH:1].[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]2[O:14][CH2:13][CH2:12][NH:11][CH2:10][C@H:9]2[CH2:22][NH:23][C:24](=[O:28])[CH2:25][O:26][CH3:27])=[CH:4][C:3]=1[F:29]参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
To a solution of tert-butyl (6R,7R)-7-(4-chloro-3-fluorophenyl)-6-{[(methoxyacetyl)amino]methyl}-1,4-oxazepane-4-carboxylate (1.11 g) in ethanol (13 mL) was added 14.0 M hydrogen chloride-ethanol solution (12.0 ml), and the mixture was stirred at room temperature for 1 hr. The crystals obtained by concentration under reduced pressure were recrystallized from ethanol-hexane to give the title compound (715 mg).
後処理
- customThe crystals obtained by concentration under reduced pressure
- customwere recrystallized from ethanol-hexane
出典と根拠
- ORDレコード
- ord-aacf8f20d29146ce8ea5aac41f771ec0
- 出典データセット
- uspto-grants-2014_05
- 特許番号
- US08722662B2
関連ノート
読み込み中…